 BALTIMORE--BUSINESS WIRE--MyMD Pharmaceuticals, Inc. MyMD and Akers Biosciences, Inc. Akers NASDAQ: AKER jointly announced a definitive merger agreement last week. The companies plan to hold a video conference for investors on Wednesday, November 18, 2020 at 4:15 p.m. ET to provide additional context on the integrated company, the clinical pipeline and drug development plan, and the commercial potential of the targeted indications. To participate in the briefing session, please clic 